Variant report

Variant	rs11881681
Chromosome Location	chr19:40917054-40917055
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:12)
CpG islands
(count:0)
Chromatin interactive
region (count:5)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:12 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	PAX5	chr19:40916966-40917277	GM12892	blood:	n/a	n/a
2	MAZ	chr19:40916993-40917500	GM12878	blood:	n/a	n/a
3	EBF1	chr19:40916824-40917821	GM12878	blood:	n/a	n/a
4	RUNX3	chr19:40916509-40917506	GM12878	blood:	n/a	n/a
5	POLR2A	chr19:40917013-40917523	GM12878	blood:	n/a	n/a
6	MTA3	chr19:40916769-40917477	GM12878	blood:	n/a	n/a
7	POLR2A	chr19:40916838-40917646	GM12892	blood:	n/a	n/a
8	POLR2A	chr19:40916949-40917443	GM12878	blood:	n/a	n/a
9	POLR2A	chr19:40916173-40917856	K562	blood:	n/a	n/a
10	MTA3	chr19:40916650-40917791	GM12878	blood:	n/a	n/a
11	POLR2A	chr19:40916986-40917624	GM12892	blood:	n/a	n/a
12	RUNX3	chr19:40916490-40917432	GM12878	blood:	n/a	n/a

No data

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:40914819..40917676-chr19:40926759..40928384,2	MCF-7	breast:
2	chr19:40916047..40918713-chr19:40928638..40931104,2	MCF-7	breast:
3	chr19:40908607..40910683-chr19:40915791..40917984,2	MCF-7	breast:
4	chr19:40915854..40917514-chr19:41102847..41104421,2	MCF-7	breast:
5	chr19:40877108..40878851-chr19:40916011..40918200,2	K562	blood:

No data

Variant related genes	Relation type
PRX	TF binding region
ENSG00000090006	Chromatin interaction
ENSG00000105223	Chromatin interaction

Extended variants
information (count: 34 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:27)

rs_ID	r²[population]
rs10408405	0.86[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs10412156	1.00[EUR][1000 genomes]
rs10422945	1.00[EUR][1000 genomes]
rs10424704	1.00[EUR][1000 genomes]
rs11879375	0.95[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs13345497	0.95[YRI][hapmap];0.95[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs13346024	1.00[EUR][1000 genomes]
rs268659	1.00[EUR][1000 genomes]
rs28407044	1.00[EUR][1000 genomes]
rs28679850	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs28728269	1.00[EUR][1000 genomes]
rs3730257	1.00[EUR][1000 genomes]
rs4150984	0.82[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs55646097	0.90[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs55860305	1.00[EUR][1000 genomes]
rs55954198	1.00[EUR][1000 genomes]
rs59129285	1.00[EUR][1000 genomes]
rs60115762	1.00[EUR][1000 genomes]
rs61018633	1.00[EUR][1000 genomes]
rs73559625	0.95[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73559626	0.95[AFR][1000 genomes];0.89[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73559635	0.97[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs73933256	1.00[EUR][1000 genomes]
rs73933258	1.00[EUR][1000 genomes]
rs73933265	1.00[EUR][1000 genomes]
rs73933270	1.00[EUR][1000 genomes]
rs73933276	1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv1826663	chr19:40529943-41023601	Enhancers Strong transcription Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	esv1833489	chr19:40722123-40923908	Enhancers Weak transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
3	nsv833831	chr19:40796740-40960865	Weak transcription Enhancers Flanking Active TSS Active TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
4	nsv911706	chr19:40842529-40969203	Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	73 gene(s)	inside rSNPs	diseases
5	nsv911707	chr19:40855255-40948202	Enhancers Weak transcription Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	61 gene(s)	inside rSNPs	diseases
6	nsv911708	chr19:40855255-40982375	Weak transcription Active TSS Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	74 gene(s)	inside rSNPs	diseases
7	esv1830682	chr19:40880127-41270055	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	139 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:65 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:40910200-40919000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
2	chr19:40910200-40926800	Weak transcription	Gastric	stomach
3	chr19:40910600-40918400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr19:40910600-40921000	Weak transcription	Fetal Kidney	kidney
5	chr19:40910600-40922800	Weak transcription	Fetal Thymus	thymus
6	chr19:40914200-40919400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
7	chr19:40914400-40917200	Weak transcription	Adipose Nuclei	Adipose
8	chr19:40914400-40922800	Weak transcription	Colonic Mucosa	Colon
9	chr19:40914400-40926600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
10	chr19:40914600-40917400	Weak transcription	Primary monocytes fromperipheralblood	blood
11	chr19:40914800-40917200	Weak transcription	K562	blood
12	chr19:40915200-40917400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr19:40915400-40923000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr19:40915600-40917200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr19:40915600-40917600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr19:40915600-40918400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
17	chr19:40915600-40918400	Enhancers	Spleen	Spleen
18	chr19:40915600-40919000	Enhancers	H1 Cell Line	embryonic stem cell
19	chr19:40915600-40919200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr19:40915800-40918000	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr19:40915800-40918200	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr19:40915800-40918200	Enhancers	Primary B cells from peripheral blood	blood
23	chr19:40916000-40917400	Enhancers	Breast Myoepithelial Primary Cells	Breast
24	chr19:40916000-40919200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr19:40916200-40919000	Weak transcription	HUES48 Cell Line	embryonic stem cell
26	chr19:40916200-40919000	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr19:40916400-40917400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
28	chr19:40916400-40918000	Enhancers	Fetal Muscle Trunk	muscle
29	chr19:40916600-40917800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
30	chr19:40916600-40917800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
31	chr19:40916600-40920200	Enhancers	Primary hematopoietic stem cells	blood
32	chr19:40916800-40917600	Flanking Active TSS	GM12878-XiMat	blood
33	chr19:40916800-40917800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
34	chr19:40916800-40918000	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr19:40916800-40918200	Enhancers	Right Atrium	heart
36	chr19:40916800-40918400	Enhancers	Fetal Heart	heart
37	chr19:40916800-40918800	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
38	chr19:40916800-40919000	Enhancers	Fetal Muscle Leg	muscle
39	chr19:40916800-40919800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr19:40916800-40921000	Enhancers	Right Ventricle	heart
41	chr19:40917000-40917200	Enhancers	H9 Cell Line	embryonic stem cell
42	chr19:40917000-40917200	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
43	chr19:40917000-40917200	Flanking Active TSS	Lung	lung
44	chr19:40917000-40917200	Enhancers	Psoas Muscle	Psoas
45	chr19:40917000-40917200	Flanking Active TSS	Stomach Smooth Muscle	stomach
46	chr19:40917000-40917200	Flanking Bivalent TSS/Enh	HepG2	liver
47	chr19:40917000-40917400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr19:40917000-40917600	Enhancers	Esophagus	oesophagus
49	chr19:40917000-40917800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr19:40917000-40918000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links